Blood-Based Biomarkers for Predicting Immunotherapy Benefit in Lung Cancer

被引：3

作者：

Camidge, D. Ross ^{[1
]}

Schenk, Erin L. ^{[1
]}

机构：

[1] Univ Colorado, Dept Med, Div Med Oncol, Anschutz Med Campus, Aurora, CO 80045 USA

来源：

CELL | 2020年 / 183卷 / 02期

关键词：

PEMBROLIZUMAB;

D O I：

10.1016/j.cell.2020.09.052

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

PD1/PD-L1-directed immunotherapy, alone or in combination with chemotherapy, dominates the initial treatment of metastatic non-small cell lung cancer. However, our ability to predict who will benefit from these approaches is limited. In this issue of Cell, Nabet et al. report a novel, blood-based methodology to more accurately predict durable disease control with immunotherapy.

引用

页码：303 / 304

页数：2

共 50 条

[1] Blood-based proteomic biomarkers for predicting response to immunotherapy in non-small cell lung cancer
Shaked, Y.
Kamer, I.
Harel, M.
Lahav, C.
Jacob, E.
Issler, E.
Dicker, A. P.
Bar, H.
Sharon, O.
Bar, J.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S849 - S849
[2] Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer
Li, Shumin
Zhang, Chengyan
Pang, Guanchao
Wang, Pingli
[J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
[3] Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC
Oitaben, Ana
Fonseca, Pablo
Villanueva, Maria J.
Garcia-Benito, Carme
Lopez-Lopez, Aida
Garrido-Fernandez, Alberto
Gonzalez-Ojea, Clara
Juaneda-Magdalena, Laura
Lazaro, Martin E.
Martinez-Fernandez, Monica
[J]. CANCERS, 2022, 14 (11)
[4] Impact of blood-based biomarkers for predicting lung cancer mortality in the PLCO cohort.
Irajizad, Ehsan
Fahrmann, Johannes F.
Vykoukal, Jody V.
Dennison, Jennifer B.
Long, James P.
Do, Kim-Anh
Ostrin, Edwin J.
Hanash, Sam
[J]. CANCER PREVENTION RESEARCH, 2023, 16 (01)
[5] Comprehensive analysis of blood-based biomarkers for predicting immunotherapy benefits in patients with advanced non-small cell lung cancer
Park, Cheol-Kyu
Oh, Hyung-Joo
Kim, Min-Seok
Koh, Bo-Gun
Cho, Hyun-Ju
Kim, Young-Chul
Yang, Hyung-Jeong
Lee, Ji-Young
Chun, Sung-Min
Oh, In-Jae
[J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2103 - +
[6] Current Readings: Blood-Based Biomarkers for Lung Cancer
Tsay, Jun-Chieh J.
DeCotiis, Christopher
Greenberg, Alissa K.
Rom, William N.
[J]. SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2013, 25 (04) : 328 - 334
[7] Blood-based Biomarkers for Immunotherapy: Applications and Limitations
Hendriks, L.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S74 - S75
[8] Contemporary Lung Cancer Screening and the Promise of Blood-Based Biomarkers
von Itzstein, Mitchell S.
Gerber, David E.
Minna, John D.
[J]. CANCER RESEARCH, 2021, 81 (13) : 3441 - 3443
[9] Blood-based tumor biomarkers in lung cancer for detection and treatment
Mamdani, Hirva
Ahmed, Shahid
Armstrong, Samantha
Mok, Tony
Jalal, Shadia I.
[J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (06) : 648 - 660
[10] Blood-based biomarkers for lung cancer: Ready for prime time?
Vachani, Anil
[J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S14 - S14

← 1 2 3 4 5 →